Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Index Rebalance

<ul>
<li>We screen the Japan equity universe ahead of the MS-Japan August 2026 quarterly review.</li>
<li>We expect one ADD and two DELETE candidates with mid to high conviction.</li>
<li>The main risk is that our estimated cutoffs or FF values.</li>
</ul>


We screen the Japan equity universe ahead of the MS-Japan August 2026 quarterly review.
We expect one ADD and two DELETE candidates with mid to high conviction.
The main risk is that our estimated cutoffs or FF values.


MS-Japan Sep 2026 Index Rebalance Forecast

Ngk Spark Plug

MS-Japan Sep 2026 Index Rebalance Forecast